Gonorrhea Clinical Trial
— FEDE-ITSOfficial title:
Extraordinarily Fun Training Project in Compulsory Secondary Education-Sexually Transmitted Infections: Educational Intervention on STI in Adolescents From 1st&2nd Year of Compulsory Secondary Education Incorporating the Gender Perspective
Project FEDE-ITS will improve the STI knowledge and its treatment, of adolescents in the 1st and 2nd year of compulsory secondary education in the intervention group compared to compared to the control group, and will modify the sexual risk practices and the perception of risky practices of alcohol and other drug use during sex of participants in the intervention group compared to the control group.
Status | Not yet recruiting |
Enrollment | 1200 |
Est. completion date | September 2023 |
Est. primary completion date | September 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 11 Years to 18 Years |
Eligibility | Inclusion Criteria: - pupils in the 1st and 2nd years of compulsory secondary education in the municipalities of Sant Andreu de la Barca, Balaguer, Alcarràs and Barcelona - prior authorisation of the school administration, - prior authorisation of the pupil - prior authorisation of the parents/legal guardians by submitting the information sheet and collecting the informed consent. Exclusion Criteria: - pupils refusing to participate - families refusing to participate - school administration refusing to participate |
Country | Name | City | State |
---|---|---|---|
Spain | CAP Alcarràs | Alcarràs | Lleida |
Spain | CAP Balaguer | Balaguer | Lleida |
Spain | CAP Gótic | Barcelona | |
Spain | CAP Sant Andreu de la Barca | Sant Andreu de la Barca | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Knowledge of the five most prevalent STIs | Discrete quantitative variable. It will be assessed by scoring. 5 scoring items: correct answer 1 point and incorrect answer 0 points. The maximum score will be 5 points (HIV: 1 point, Chlamydia: 1 point, Syphilis or Treponema pallidum: 1 point, Gonorrhoea or Neisseria gonorrhoeae: 1 point, HPV or Papilloma Virus: 1 point), and the minimum 0 points.
- "List the Sexually Transmitted Infections (STIs) you know, Tick one: HIV Candida albicans Gonorrhoea Chlamydia Escherichia coli Treponema / Syphilis COVID-19 Human Papilloma (HPV)" |
pre-intervention at the baseline day | |
Primary | Knowledge of the five most prevalent STIs | Discrete quantitative variable. It will be assessed by scoring. 5 scoring items: correct answer 1 point and incorrect answer 0 points. The maximum score will be 5 points (HIV: 1 point, Chlamydia: 1 point, Syphilis or Treponema pallidum: 1 point, Gonorrhoea or Neisseria gonorrhoeae: 1 point, HPV or Papilloma Virus: 1 point), and the minimum 0 points.
- "List the Sexually Transmitted Infections (STIs) you know, Tick one: HIV Candida albicans Gonorrhoea Chlamydia Escherichia coli Treponema / Syphilis COVID-19 Human Papilloma (HPV)" |
end-of-intervention at the same day | |
Primary | Knowledge of the five most prevalent STIs | Discrete quantitative variable. It will be assessed by scoring. 5 scoring items: correct answer 1 point and incorrect answer 0 points. The maximum score will be 5 points (HIV: 1 point, Chlamydia: 1 point, Syphilis or Treponema pallidum: 1 point, Gonorrhoea or Neisseria gonorrhoeae: 1 point, HPV or Papilloma Virus: 1 point), and the minimum 0 points.
- "List the Sexually Transmitted Infections (STIs) you know, Tick one: HIV Candida albicans Gonorrhoea Chlamydia Escherichia coli Treponema / Syphilis COVID-19 Human Papilloma (HPV)" |
post-intervention assessments six months after the intervention | |
Primary | Knowledge of different barrier methods. | Discrete quantitative variable. It will be collected in the questionnaire using a question with multiple correct options. There will be 5 options and 2 correct. Scoring: From 0 (minimum score) to 5 points (maximum score)
- "How many barrier methods do you know? (tick the options you consider * correct): Select all the options that apply. Male condom Post-coital pill Aspirin Abstinence Female condom" |
pre-intervention at the baseline day | |
Primary | Knowledge of different barrier methods. | Discrete quantitative variable. It will be collected in the questionnaire using a question with multiple correct options. There will be 5 options and 2 correct. Scoring: From 0 (minimum score) to 5 points (maximum score)
- "How many barrier methods do you know? (tick the options you consider * correct): Select all the options that apply. Male condom Post-coital pill Aspirin Abstinence Female condom" |
end-of-intervention at the same day | |
Primary | Knowledge of different barrier methods. | Discrete quantitative variable. It will be collected in the questionnaire using a question with multiple correct options. There will be 5 options and 2 correct. Scoring: From 0 (minimum score) to 5 points (maximum score)
- "How many barrier methods do you know? (tick the options you consider * correct): Select all the options that apply. Male condom Post-coital pill Aspirin Abstinence Female condom" |
post-intervention assessments six months after the intervention | |
Primary | Use of barrier methods in sexual intercourse. | Ordinal qualitative variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never)
- In the case of having sex, have you used barrier methods (condom or female condom) from the very start (including oral sex), OR If you do not have sex, do you think that when you do have sex you will always use barrier methods (condom-female condom), including oral sex? Tick one. Always Almost Always Sometimes Never |
pre-intervention at the baseline day | |
Primary | Use of barrier methods in sexual intercourse. | Ordinal qualitative variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never)
- In the case of having sex, have you used barrier methods (condom or female condom) from the very start (including oral sex), OR If you do not have sex, do you think that when you do have sex you will always use barrier methods (condom-female condom), including oral sex? Tick one. Always Almost Always Sometimes Never |
end-of-intervention at the same day | |
Primary | Use of barrier methods in sexual intercourse. | Ordinal qualitative variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never)
- In the case of having sex, have you used barrier methods (condom or female condom) from the very start (including oral sex), OR If you do not have sex, do you think that when you do have sex you will always use barrier methods (condom-female condom), including oral sex? Tick one. Always Almost Always Sometimes Never |
post-intervention assessments six months after the intervention | |
Primary | Drug use during sexual intercourse. | Qualitative ordinal variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never)
- "If you have sex, do you use alcohol or other drugs when you have sex? OR If you do not have sex, do you think that when you do you will use * alcohol or other drugs when you have sex? Tick one. Always Almost Always Sometimes Never |
pre-intervention at the baseline day | |
Primary | Drug use during sexual intercourse. | Qualitative ordinal variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never)
- "If you have sex, do you use alcohol or other drugs when you have sex? OR If you do not have sex, do you think that when you do you will use * alcohol or other drugs when you have sex? Tick one. Always Almost Always Sometimes Never |
end-of-intervention at the same day | |
Primary | Drug use during sexual intercourse. | Qualitative ordinal variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never)
- "If you have sex, do you use alcohol or other drugs when you have sex? OR If you do not have sex, do you think that when you do you will use * alcohol or other drugs when you have sex? Tick one. Always Almost Always Sometimes Never |
post-intervention assessments six months after the intervention | |
Secondary | Role in sexual intercourse. | Nominal qualitative variable. It will be recorded in the questionnaire using multiple-choice questions.
"If you have sex, who decides whether or not to use a barrier method of contraception (condom - female condom)? OR If you do not have sex, who do you think will decide whether or not to use * a barrier method of contraception (condom-female condom) when you do have sex Tick one. Myself My sexual partner We decide by mutual consent Other (specify) |
pre-intervention at the baseline day | |
Secondary | Role in sexual intercourse. | Nominal qualitative variable. It will be recorded in the questionnaire using multiple-choice questions.
"If you have sex, who decides whether or not to use a barrier method of contraception (condom - female condom)? OR If you do not have sex, who do you think will decide whether or not to use * a barrier method of contraception (condom-female condom) when you do have sex Tick one. Myself My sexual partner We decide by mutual consent Other (specify) |
end-of-intervention at the same day | |
Secondary | Role in sexual intercourse. | Nominal qualitative variable. It will be recorded in the questionnaire using multiple-choice questions.
"If you have sex, who decides whether or not to use a barrier method of contraception (condom - female condom)? OR If you do not have sex, who do you think will decide whether or not to use * a barrier method of contraception (condom-female condom) when you do have sex Tick one. Myself My sexual partner We decide by mutual consent Other (specify) |
post-intervention assessments six months after the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01439503 -
Safer Sex Program for Young African-American Men
|
Phase 2 | |
Completed |
NCT00381992 -
Risk Assessment of Long-Haul Truck Drivers
|
N/A | |
Completed |
NCT03294395 -
New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea
|
Phase 3 | |
Not yet recruiting |
NCT06428643 -
A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
|
N/A | |
Completed |
NCT03896776 -
A Pragmatic Trial of Two Strategies for Implementing an Effective eHealth HIV Prevention Program (Keep It Up! 3.0)
|
N/A | |
Completed |
NCT03718806 -
Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin
|
Phase 1 | |
Completed |
NCT04010539 -
A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea
|
Phase 3 | |
Completed |
NCT00187902 -
Evaluation of NAATs for Detection of C. Trachomatis and N. Gonorrhoeae From Pharynx, Rectum, Glans & Urethra of MSM
|
N/A | |
Completed |
NCT00262106 -
Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
|
Phase 3 | |
Completed |
NCT00207506 -
Lay Health Advisors for Sexually Transmitted Disease Prevention
|
Phase 1/Phase 2 | |
Completed |
NCT04553068 -
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
|
Phase 3 | |
Active, not recruiting |
NCT03959527 -
Zoliflodacin in Uncomplicated Gonorrhoea
|
Phase 3 | |
Active, not recruiting |
NCT03980223 -
Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men
|
Phase 4 | |
Completed |
NCT01465607 -
Implementation of an Efficacious Intervention for High Risk Women in Mexico
|
N/A | |
Terminated |
NCT00120770 -
Cellulose Sulfate (CS) Gel and HIV in Nigeria
|
Phase 3 | |
Completed |
NCT02391233 -
Multimedia WORTH With Black Drug-Involved Women on Probation
|
N/A | |
Recruiting |
NCT05766904 -
Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections
|
Phase 3 | |
Completed |
NCT04297436 -
Gonococcal Vaccine Study in Key Populations in Kenya
|
N/A | |
Completed |
NCT03098329 -
Check it: A New Approach to Controlling Chlamydia Transmission in Young People
|
N/A | |
Completed |
NCT02122094 -
Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities
|
N/A |